Positive Women in Asella Town Government Health Facilities, Ethiopia, 2018. A Facility Based Cross sectional Study.
DOI:
https://doi.org/10.20372/ajsi.v6i1.3193Keywords:
Antiretroviral, human-immune virus, human-immune virus Exposed infant, mother-to-child transmissionAbstract
Background: Globally there are 3.3 million Children under fifteenyears of
age living with human-immune virus infection each year. Itcan be
transmitted from human-immune virus positive mothers to her child during
pregnancy, childbirth and breast feeding. Without treatment, the likelihood
of itstransmissionfrom mother-to-child is fifteen toforty five percent.
Therefore, the purpose of this study was to reveal theitsprevalence among
infants born to sero positive mothers.
Method: Facility based cross-sectional study was employed among
220human-immune virusexposed infants enrolled from July 1, 2014- June30,
2018 in Asella town Health facilities. Data werecollected from all exposed
infant having human-immune virus Deoxyribonucleic Acid polymerase chain
reaction test. The collected data was coded and entered in to EPI info
version 7.0, then cleaned and exported to SPSS version 21. Descriptive
statistics were used to describe findings, both binary and then multiple
logistic regressions were used to identify the associated factors. A 95%
confidence intervalwith Adjusted odd ratiowas used to measure the strengths
of association and a p-value <0.05 was used to determine the statistical
significance in the final model.
Result: The study revealed that 2.3% of the infants born from humanimmune
virus seropositive mothers were found to be human-immune virus
positive. Infants whose mothers started Antiretroviral at post-partum period 46.794, 95%CI (6.521, 321.590)).
Conclusion:The prevalence of human-immune virus infection among
exposed infants was less than globally expected for mothers only breastfeed
their infants to acceptable level. Initiating Antiretroviral during post-partum
period was the factor associated with mother-to-child transmission.
Therefore, mothers should start Antiretroviral early to bring mother-to-child
transmission to zero level and further investigations are recommended to
identify more predictors.